Journal of Bioethical Inquiry

, Volume 6, Issue 1, pp 141–143 | Cite as


  • Diana M BowmanEmail author

The Therapeutic Goods Administration (TGA) is charged with the responsibility of safeguarding public health by ensuring the quality, safety, efficacy and timely availability of therapeutic goods within Australia. This is achieved through a combination of manufacturing principles, pre-market risk assessments and post-market monitoring processes. Sunscreen products with a SPF factor of 4 or above are defined as a therapeutic good (TGA 2003), and therefore fall within the regulatory scope of the TGA. The majority of these sunscreen products are defined as “listable goods”, and assessed by the TGA on the basis of their quality and safety; they are therefore not required to assess the efficacy of the sunscreen prior to its listing, and rely instead on the scientific evidence supplied by the applicant. Prime facie, it is therefore possible to assume that all current sunscreens that fall under the regulatory scope of the TGA—regardless of whether or not they contain nanoparticles—are safe...


Zinc Oxide Nanoscale Material Therapeutic Good Administration Therapeutic Good Viable Epidermis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Bowman, D., & Fitzharris, M. 2007. Too small for concern? Public health and nanotechnology. Australian and New Zealand Journal of Public Health, 31(4), 382–384. doi: 10.1111/j.1753-6405.2007.00092.x.PubMedCrossRefGoogle Scholar
  2. European Commission. 2008. Public health (03-03-2008): Revision of risk-assessment methods needed to evaluate potential risks in the use of certain nanomaterials in cosmetic products. Brussels: EC.Google Scholar
  3. Faunce, T., K. Murray, H. Nasu, D.M. Bowman, et al. 2008. Sunscreen safety: The precautionary principle, the Australian Goods Administration and nanoparticles in sunscreens. NanoEthics, 2(3), forthcoming.Google Scholar
  4. Food and Drug Administration. 2007. Nanotechnology: A report of the U.S. Food and Drug Administration nanotechnology task force p. 35. Washington DC: FDA.Google Scholar
  5. Friends of the Earth. 2006. Nanomaterials, sunscreens and cosmetics: Small ingredients, big risks. Sydney: Friends of the Earth Australia and Friends of the Earth United States.Google Scholar
  6. International Centre for Technology Assessment. 2006. Citizen petition to the United States Food and Drug Administration. Washington DC: CTA.Google Scholar
  7. Nohynek, G.J., Lademann, J., Ribaud, C., & Roberts, M.S. 2007. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Critical Reviews in Toxicology, 37(3), 251–277. doi: 10.1080/10408440601177780.PubMedCrossRefGoogle Scholar
  8. Nohynek, G.J., Dufour, E.K., & Roberts, M.S. 2008. Nanotechnology, cosmetics and the skin: Is there a health risk? Skin Pharmacology and Applied Skin Physiology, 21, 136–139. doi: 10.1159/000131078.CrossRefGoogle Scholar
  9. Scientific Committee on Consumer Products. 2005. Scientific Committee on Consumer Products (SCCP): Request for a scientific opinion: Safety of nanomaterials in cosmetic products. Brussels: Health & Consumer Protection Directorate-General.Google Scholar
  10. Scientific Committee on Consumer Products. 2007. Opinion on Safety of nanomaterials in cosmetic products, December. Brussels: Health & Consumer Protection Directorate-General.Google Scholar
  11. Swiss Re. 2004. Nanotechnology: Small matter, many unknowns. Geneva: Swiss Re.Google Scholar
  12. Therapeutic Goods Administration. 2003. Australian regulatory guidelines for OTC medicines. Canberra: Commonwealth Department of Health and Ageing.Google Scholar
  13. Therapeutic Goods Administration. 2006a. A review of the scientific literature on the safety of nanoparticulate titanium dioxide and zinc oxide in sunscreens. Canberra: Commonwealth Department of Health and Ageing.Google Scholar
  14. Therapeutic Goods Administration. 2006b. Safety of sunscreens containing nanoparticles of zinc oxide or titanium dioxide. Canberra: Commonwealth Department of Health and Ageing.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  1. 1.Monash Centre for Regulatory Studies, Faculty of LawMonash UniversityClaytonAustralia
  2. 2.Institute for Environment and Energy Law, Faculty of LawKU LeuvenLeuvenBelgium

Personalised recommendations